C
TYRA icon

Covestor’s Tyra Biosciences TYRA Stock Holding History

Covestor’s Portfolio TYRA Stock Details TYRA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$1K Buy
16
+10
+167% +$331 ﹤0.01% 2360
2026
Q1 		$0 Hold
6
– – ﹤0.01% 2786
2025
Q4 		$0 Hold
6
– – ﹤0.01% 2753
2025
Q3 		$0 Hold
6
– – ﹤0.01% 2793
2025
Q2 		$0 Hold
6
– – ﹤0.01% 2774
2025
Q1 		$0 Hold
6
– – ﹤0.01% 2745
2024
Q4 		$0 Hold
6
– – ﹤0.01% 2756
2024
Q3 		$0 Hold
6
– – ﹤0.01% 2786
2024
Q2 		$0 Buy
+6
New +$103 ﹤0.01% 2776

Other funds holding TYRA

RCM
RA Capital Management Boston, Massachusetts $11.5B AUM 168.77% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
JT
Jupiter Topco New York $245B AUM
APMC
Alta Partners Management Company Jackson, Wyoming $127M AUM 230.85% 1-Year Est. Return
NI
Nextech Invest Zurich, Switzerland $2.11B AUM 413.84% 1-Year Est. Return
TCM
TCG Crossover Management Palo Alto, California $4.16B AUM 983.43% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
CC
Commodore Capital New York $1.68B AUM 375.52% 1-Year Est. Return

Covestor's TYRA Position: Q2 2026 in Review

Covestor increased its Tyra Biosciences (TYRA) stake by 167% in Q2 2026, buying an estimated $331 and bringing the position to 16 shares worth $1K. The position accounts for ﹤0.01% of the portfolio, ranked #2360.

Covestor first reported a position in TYRA in Q2 2024 and has held it in 9 quarters since. 168 funds tracked by Wall St. Rank hold TYRA as of Q2 2026.

  • Covestor held 16 shares of Tyra Biosciences worth $1K as of Q2 2026.
  • Covestor bought 10 Tyra Biosciences shares in Q2 2026, an estimated $331.
  • Tyra Biosciences made up ﹤0.01% of Covestor's portfolio in Q2 2026, its #2360 holding.
  • Covestor first reported a position in Tyra Biosciences in Q2 2024 and has held it in 9 quarters since.
  • 168 funds tracked by Wall St. Rank held Tyra Biosciences as of Q2 2026.

Based on Covestor's 13F filing for Q2 2026, filed 7 Aug 2026.